ABSTRACT Sodium ion (Na+) influences binding of both dopamine agonists and antagonists to D2 receptors in striatum and retina. Also, Na+ markedly potentiates the loss of high-affinity agonist binding due to the GTP analogue p[NH]ppG. 2-Amino-6, 7-dihydroxy-1,2,3,4-tetrahydro [5,8-3H] H]-domperidone in striatum label a common D2 receptor population. Na+ alters the pharmacological properties of these receptors and is required for guanine nucleotide to enhance the rate of agonist dissociation from these receptors. A model is proposed involving separate but interrelated effects of Na+ and guanine nucleotide on receptor conformation. In the presence of Na+ these receptors assume a conformation that corresponds to the biological activity of D2 receptor agonists and antagonists in vivo. In the presence of both Na+ and guanine nucleotide the receptors lose sensitivity to agonists but retain sensitivity to antagonists. METHODS Rat and bovine striatal and retinal membranes were prepared and binding assays carried out as described (13, (17) (18) (19) (1 mM MgCl2/100 mM NaCl/4 mM KC/2, mM CaCl2) used in previous studies (13, 17, 20 5, 6, 7, 8, 8a, 9-octahydro-5-n-propyl-2H-pyrazolo[3,4-g] ADTN, 2, 3, The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
A number of receptor systems including the a2-noradrenergic and opiate systems are influenced both by GTP or related guanine nucleotide analogues and by sodium ion (Na+) (1) (2) (3) (4) (5) (6) (7) (8) (9) . Both guanine nucleotides and Na+ decrease the affinity of agonists for the receptor. Guanine nucleotides are involved in coupling to adenylate cyclase ofreceptors that function either to activate or to inhibit adenylate cyclase (1) . On the other hand, Na+ is involved predominantly in regulation of receptors that either are not linked to adenylate cyclase or that function to inhibit adenylate cyclase (1, 4, 7, 9) . Dopamine receptors in striatum and retina appear to constitute' heterogeneous populations of sites (10) (11) (12) (13) . The clearest functional and biochemical evidence for dopamine receptor heterogeneity is for a population of dopamine receptors (D1) mediatingdopamine stimulation ofadenylate cyclase and for another population (D2) either not linked to adenylate cyclase (14) or, as appears to be the case in the intermediate lobe ofthe pituitary, mediating dopamine inhibition ofadenylate cyclase (15) . It'has been demonstrated also that the presence of Na+ is necessary for the dopamine antagonist, sulpiride, and certain other benzamides to effectively compete for [3H]spiroperidol binding sites in rat striatum (16) .
The present study examines the influence of Na+ on the pharmacology and guanine-nucleotide sensitivity of both dopamine agonist (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydro [5,8-3H] [3 H]-domperidone in striatum label a common D2 receptor population. Na+ alters the pharmacological properties of these receptors and is required for guanine nucleotide to enhance the rate of agonist dissociation from these receptors. A model is proposed involving separate but interrelated effects of Na+ and guanine nucleotide on receptor conformation. In the presence of Na+ these receptors assume a conformation that corresponds to the biological activity of D2 receptor agonists and antagonists in vivo. In the presence of both Na+ and guanine nucleotide the receptors lose sensitivity to agonists but retain sensitivity to antagonists. METHODS Rat and bovine striatal and retinal membranes were prepared and binding assays carried out as described (13, (17) (18) (19) (1 mM MgCl2/100 mM NaCl/4 mM KC/2, mM CaCl2) used in previous studies (13, 17, 20) . Assays with [3H]ADTN were carried out for routine (standard) assay with 1 mM. MnCl2 as described (13, 18, 21) or with 1 mM MgCl2 in place of MnCl2, with or without 100 mM NaCl, as indicated in the text. Total specific binding represented the difference between total binding.and that found in the presence of 10 ,uM (+)-butaclamol (13, 18, 19 Tables 1 and 2 . Striatum, without NaCl (o) and with NaCl (e). Retina, without NaCl (A) and with NaCl (A). (Fig. 3B) Influence of Na' on Antagonist Radioligand Binding and Competition for this Binding by Agonist. Saturation studies of striatal binding of [3H]spiroperidol (from 0.02 to 1.0 nM), analyzed as described above (31) , showed a single binding component, with an increase in Bm. due to Na+. Bm. values were 265 ± 21 and 342 ± 22 fmol/mg ofprotein and Kd values were 0.49 ± 0.05 and 0.38 ± 0.04 nM in the absence and presence of 100 mM NaCI, respectively. This increase in Bma is believed to be due to the conversion of receptors having antagonist affinity too low to be measured in the absence of Na+ to a conformation with high antagonist affinity in the presence of Na+. In equilibrium binding studies, both in striatum and retina [3H]spiroperidol binding was enhanced by Na+ (Table 3) but not by KCI (data not shown), nor was binding altered by p [NH] ppG either in the presence or absence of NaCl (Table  3) .
DISCUSSION
The present study provides evidence concerning the pharmacological properties of D2 receptor sites and the regulation of these sites by Na+ and guanine nucleotide in striatum and retina. It is shown that dopamine agonist binding sites labeled by [3H] ADTN in both regions are of the D2 type. This conclusion-which differs from that proposed in previous studies for both striatum and retina (13, 18, 19, 21, 32) -is based on the affinities of selective D2 antagonists and of the D2 agonist LY-141865, assessed in the presence of Na+. The relative affinities of these drugs support the biological importance of the [3H]-ADTN binding sites. Also, relative affinities for the structurally related dopamine agonists pergolide and LY-141865 correspond to the relative potencies ofthese drugs for induction ofrotational behavior in rats with unilateral lesions of the nigrostriatal dopamine pathway and for inhibition of prolactin release in vivo (22 (2) (3) (4) and muscarinic (8, 9) receptor systems, though there appear to be independent effects of Na+ and GTP on the a2-noradrenergic system (5-7). For both the opioid system (27, 33) and the D2 system reported here, Mn2+ antagonizes the effect of Na+ on agonist binding and Na+ enhances antagonist binding.
In the present study in both striatum and retina, with Na+ present essentially all remaining high affinity dopamine agonist binding sites were sensitive to p[NH]ppG under appropriate conditions. We therefore postulate that [3H]ADTN binds with different affinities to different conformational states of the D2 receptor and the Na+ and guanine nucleotides exert separate but interrelated influences on the receptor conformation, as also appears to be the case for opioid agonist binding (3, 34 
